Library

Home > Library

Search results : regulation

Bidenomics 2.0: trade, taxation, and technology

2024-02-14This ebook delves into key financial topics and stock market investment articles.

This AYA analytic ebook delves into the macroeconomic and technological aspects of Bidenomics from mid-2020 to present. This ebook comprises 4 main parts. The first part explains the pre-Biden Trump economic policy reforms in t...+See More
Bidenomics

2022-09-21This ebook delves into key financial topics and stock market investment articles.

This AYA analytic ebook delves into the macroeconomic and technological aspects of Bidenomics from mid-2020 to present. This ebook comprises 3 main parts. The first part explains the pre-Biden Trump economic policy reforms in t...+See More
Bank leverage and capital bias adjustment through the macroeconomic cycle

2020-12-31This simulation study delves into the quantitative effects of the recent proposal for more robust bank capital adequacy.

This simulation study delves into the quantitative effects of the recent proposal for more robust bank capital adequacy.+See More
Key motifs in the merry medley of Trump economic reform 2016-2020

2020-06-06This ebook delves into key financial topics and stock investment memes blog posts and essays.

This ebook offers the key motifs in the merry medley of Trump economic reform 2016-2020: (1) Federal Reserve monetary policy decisions and interest rate adjustments in response to inflationary fluctuations, economic output g...+See More
Algorithmic credit portfolio segmentation

2013-06-06This research article proposes a new algorithmic model for credit portfolio segmentation.

This research article proposes a new algorithmic model for credit portfolio segmentation.+See More
1

Blog+More

BlackRock CEO Larry Fink suggests that corporations should make a positive contribution to society apart from boosting the bottomline.

Olivia London

2018-01-09 08:33:00 Tuesday ET

BlackRock CEO Larry Fink suggests that corporations should make a positive contribution to society apart from boosting the bottomline.

BlackRock CEO Larry Fink emphasizes his key conviction that public corporations should make a positive contribution to society apart from boosting the botto

+See More

New York Fed CEO John Williams listens to sharp share price declines as part of the data-dependent interest rate policy.

Dan Rochefort

2019-01-02 06:28:00 Wednesday ET

New York Fed CEO John Williams listens to sharp share price declines as part of the data-dependent interest rate policy.

New York Fed CEO John Williams listens to sharp share price declines as part of the data-dependent interest rate policy. The Federal Reserve can respond to

+See More

Former Bank of England Governor Mervyn King provides his deep substantive analysis of the Global Financial Crisis of 2008-2009.

Monica McNeil

2023-03-07 11:29:00 Tuesday ET

Former Bank of England Governor Mervyn King provides his deep substantive analysis of the Global Financial Crisis of 2008-2009.

Former Bank of England Governor Mervyn King provides his deep substantive analysis of the Global Financial Crisis of 2008-2009. Mervyn King (2017) &nb

+See More

Top 4 U.S. richest people are self-made billionaires: Gates, Buffet, Bloomberg, and Zuckerberg.

Dan Rochefort

2017-08-01 09:40:00 Tuesday ET

Top 4 U.S. richest people are self-made billionaires: Gates, Buffet, Bloomberg, and Zuckerberg.

In American states, all of the Top 4 richest people are self-made billionaires: Bill Gates in Washington, Warren Buffett in Nebraska, Michael Bloomberg in N

+See More

PwC releases a new study of top innovators worldwide as of November 2018.

Daphne Basel

2018-11-07 08:30:00 Wednesday ET

PwC releases a new study of top innovators worldwide as of November 2018.

PwC releases a new study of top innovators worldwide as of November 2018. This study assesses the top 1,000 global companies that spend the most on R&D

+See More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More